Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma

Journal of Hepatology

Volumn 27, Issue 4, 1997, Pages 669-676

  Tamura, Sumihito ^a   Nakamori, Shoji ^a   Kuroki, Tamotsu ^b   Sasaki, Yo ^a   Furukawa, Hiroshi ^a   Ishikawa, Osamu ^a   Imaoka, Shingi ^a   Nakamura, Yusuke ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aggressiveness; Biological characteristics; Hepatocellular carcinoma; Loss of heterozygosity; Microsatellite marker; Polymerase chain reaction; Progression

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HETEROZYGOSITY LOSS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL TIME;

EID: 0030848562     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80084-0     Document Type: Article

References (39)

1. Colombo M. Hepatocellular carcinoma. J Hepatol. 15:1992;225-236.
2. Osaka K, Kojiro M, Okuda H. Neoplasms of the liver. Schiff L, Schiff ER. 7th ed. Disease of the Liver. 1993;1236-1296 J.B. Lippincott, Philadelphia.
3. Kanematsu T, Matsumata T, Takenaka K, Yoshida Y, Higashi H, Sugimachi K. Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg. 75:1988;203-206.
4. Nagasue N, Kohno H, Chang Y, Taniura H, Yamanoi A, Uchida M, et al. Liver resection for hepatocellular carcinoma. Ann Surg. 217:1993;375-384.
5. Kakazu T, Makuuchi M, Kawasaki S, Miyagawa S, Hashikura Y, Kosuge T, et al. Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology. 40:1993;337-341.
6. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer. 74:1994;2772-2780.
7. Lai E, Fan S, Lo C, Chu K, Liu C, Wong J. Hepatic resection for hepatocellular carcinoma. Ann Surg. 221:1995;291-298.
8. Norwell P. Mechanisms of tumor progression. Cancer Res. 46:1986;2203-2207.
9. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet. 25:1991;281-314.
10. Solomon E, Borrow J, Goddard A. Chromosome aberrations and cancer. Science. 254:1991;1153-1160.
11. Ding S-F, Habib NA. Loss of heterozygosity in liver tumors. J Hepatol. 22:1995;230-238.
12. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52:1992;6358-6364.
13. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6791-6794.
14. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T, et al. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer. 13:1995;163-167.
15. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, et al. Accumulation of allelic loss on arms of chromosomes 13q, 16q, and 17p in the advanced stage of human hepatocellular carcinoma. Int J Cancer. 51:1992;862-868.
16. Emi M, Fujiwara Y, Ohta H, Tsuda H, Hirohashi S, Koike M, et al. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Gene Chromosomes Cancer. 7:1993;152-157.
17. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Sato C, Tsuruta K, Maeda Y, et al. Genetic changes and histopathological grades in human hepatocellular carcinomas. Jpn J Cancer Res. 84:1993;893-899.
18. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
19. Hamilton S. The molecular genetics of colorectal neoplasia. Gastroenterology. 105:1993;3-7.
20. Kern S, Fearon E, Tersmett K, Enterline J, Leppert M, Nakamura Y, et al. Allelic loss in colorectal carcinoma. JAMA. 261:1989;3099-3103.
21. American Joint Committee on Cancer. 3rd ed. Manual for Staging of Cancer. 1987;Lippincott, Philadelphia.
22. Edmondson H, Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48 900 neocropsies. Cancer. 7:1954;462-503.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
24. Yeh S-H, Chen P-J, Chen H-L, Lai M-Y, Wang C-C, Chen D-S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 54:1994;4188-4192.
25. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, et al. The 1993-94 Genethon human genetic linkage map. Nature Genet. 7:1994;246-339.
26. Jones MH, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotie repeat polymorphism. Genes Chromosomes Cancer. 5:1992;89-90.
27. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
29. Cox D. Regression models and life-tables. J R Stat Soc (B). 34:1972;187-220.
30. Harmanek P, Sobin L. 4th ed. UICC: TNM Classification of Malignant Tumors. 1987;Springer-Verlag, New York.
31. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology. 106:1994;1618-1624.
32. 3rd ed. The general rules for the Clinical and Pathological Study of Primary Liver Cancer. 1992;Kanehara Press, Tokyo.
33. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 106:1994;720-727.
34. Wiggers T, Arends J, Schutte B, Volovics L, Bosman F. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer. 61:1988;1068-1072.
35. National Institutes of Health Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 264:1990;1447-1450.
36. Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer. 69:1992;913-919.
37. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 71:1993;19-25.
38. Beasley R. Hepatitis B virus; the major etiology of hepatocellular carcinoma. Cancer. 61:1988;1942-1956.
39. Saito I, Miyamura M, Ohbayashi A, Harada H, Katayama T, Kikuti S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6547-6549.